The encyclopedia · Strategy & Leadership · Operational decision · 2015–2026
Jan Aushadhi sold trusted generics at 50–80% off via 18,000+ franchise stores
PMBJP's franchise stores sell GMP-only, batch-tested generics at 50–80% below branded prices — saving Indian citizens an estimated ₹40,000 crore.
Pharmaceuticals & Medical Devices Bureau (PMBI)
The solution
Medicine is one of the largest items in Indian households' out-of-pocket health spending, and branded generics cost far more than unbranded equivalents with identical therapeutic value. The government's PMBJP scheme attacked that gap by building its own generic-drug retail chain.
The design is a trust machine. PMBI procures only from WHO-GMP-certified plants, draws samples from 100% of batches at its warehouses, and releases stock only after testing at NABL-accredited laboratories. The medicines then flow to Jan Aushadhi Kendras — franchise outlets run by pharmacists, NGOs, societies, cooperatives and individual entrepreneurs.
Franchisees earn trade margins plus performance-linked incentives, and one-time grants support stores in aspirational districts, Himalayan, island and North-Eastern regions, and outlets run by women, SC/ST, divyangjan and ex-servicemen entrepreneurs. Five central warehouses and 41 distributors feed the network, with 116 outlets in railway stations alone.
Prices run 50–80% below branded equivalents. By 28 February 2026 there were 18,646 Kendras against a 25,000 target for March 2027, and PIB estimates the scheme saved citizens about ₹40,000 crore of out-of-pocket spending over 11 years.
Why it worked
- GMP-only procurement plus 100% batch testing defeated the core objection that cheap generics are poor quality.
- Franchise economics — margins and stocking incentives — made rural outlets viable without a government payroll.
- Transparent MRP comparisons via the Jan Aushadhi Sugam app made the saving visible to patients.
- Placement in hospitals, stations and cooperative networks put generics where low-income patients already are.
What can be applied
A discount brand needs trust and reach, not just a lower price: Jan Aushadhi paired GMP-only supply and 100% batch testing with franchise stores whose owners earn margins.
Aftermath
By 28 February 2026, 18,646 Jan Aushadhi Kendras were open against a target of 25,000 by March 2027. The portfolio covers 2,110 medicines and 315 surgical items across 29 therapeutic categories, roughly 10–12 lakh people visit the stores daily, and PIB puts cumulative citizen savings at about ₹40,000 crore over 11 years — a franchise-built generic chain now treated as a pillar of affordable healthcare.
Sources
- Expansion of PMBJKs to Reduce Healthcare Costs
- PIB Backgrounder: Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
spotted an error? The archive wants to know.